𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature

✍ Scribed by P Solves; P Bolufer; J.A López; E Barragán; L Bellod; S Ferrer; A Rosell; E Lerma; J Cervera; J de la Rubia; G.F Sanz; M.Á Sanz Alonso


Book ID
114119651
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
370 KB
Volume
23
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Is it possible to discontinue imatinib m
✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o